Clinical Trials


Boolean Natural Query Expansion

HYMN: A Randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guérin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guérin therapy.

This trial is looking at a new treatment for superficial bladder cancer called microwave induced hyperthermia use with local chemotherapy. This will be compared to the standard treatments that are currently available for these patients.

Patient recruitment is planned to start Spring 2010 and complete Spring 2013. Around 242 Patients will be enrolled from 20 plus NHS centres across the UK.

This trial is funded by Cancer Research UK, coordinated by the University of Birmingham CRUK- Clinical Trials Unit and sponsored by University College London.

Start date: 1 Mar 2010
Finish date: 1 Mar 2013
Chief Investigator - Prof John Kelly, UCLH
[Complete article]

Mon, 1st Jun, 2020